Report of Foreign Issuer (6-k)
June 16 2017 - 8:23AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13A-16 OR 15D-16 UNDER THE
SECURITIES
EXCHANGE ACT OF 1934
Dated
June
16, 2017
Commission
File Number
001-36421
AURINIA PHARMACEUTICALS INC.
(Exact
name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s Name)
#1203-4464 Markham Street
Victoria, British Columbia
V8Z7X8
(250)
708-4272
(Address and telephone number of registrant’s
principal executive offices)
Indicate by
check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form 20-F
⃞
Form 40-F
⊠
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1):
⃞
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):
⃞
Indicate by
check mark whether by furnishing the information contained in this Form,
the registrant is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act
of 1934.
Yes
⊠
No
⃞
This Form 6-K is hereby filed and incorporated by reference into the
Registrant’s Registration Statement on Form F-10 (File No. 333-206994).
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated June 6 2017.
|
|
|
|
|
Aurinia Pharmaceuticals Inc.
|
|
|
|
By:
|
/s/ Celia Economides
|
|
|
Name:
|
Celia Economides
|
|
|
Title:
|
Vice President, Public Affairs
|
EXHIBIT INDEX
Exhibit
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
News Release –
Voclosporin Remission Data from the Phase
IIb AURA-LV Study Highlighted at EULAR 2017
|
Exhibit 99.1 included with this report on Form 6-K is hereby
incorporated by reference as an exhibit to the Registrant’s Registration
Statement on Form F-10 (File No. 333-206994), as amended or supplemented.
3
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Sep 2023 to Sep 2024